Stock HCT HOLISTA COLLTECH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Holista Colltech Limited

Equities

HCT

AU000000HCT4

Biotechnology & Medical Research

Market Closed - Australian S.E.
Other stock markets
 01:10:13 2024-03-14 EDT 		5-day change 1st Jan Change
0.01 AUD +11.11% Intraday chart for Holista Colltech Limited -.--% -.--%
05-15 Holista Colltech Extends Voluntary Suspension to May 22 MT
04-17 Holista Colltech Requests for Extension of Voluntary Suspension MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 13.57 18.49 19.83 12.94 8.085 2.788
Enterprise Value (EV) 1 14.1 19.31 18.04 12.62 9.188 4.296
P/E ratio -7.44 x -26.8 x -3.53 x -10.2 x -5.53 x -0.58 x
Yield - - - - - -
Capitalization / Revenue 1.69 x 2.5 x 2.7 x 1.61 x 0.98 x 0.47 x
EV / Revenue 1.75 x 2.61 x 2.46 x 1.57 x 1.11 x 0.72 x
EV / EBITDA -9.73 x -24.5 x -4.38 x -12.3 x -7.51 x -1.54 x
EV / FCF -6.14 x 70.2 x -7.81 x -14.2 x -14.2 x 1.71 x
FCF Yield -16.3% 1.42% -12.8% -7.03% -7.06% 58.3%
Price to Book 2.54 x 4.18 x 3.66 x 3.16 x 2.86 x -1.41 x
Nbr of stocks (in thousands) 234,039 234,039 275,349 275,349 278,800 278,800
Reference price 2 0.0580 0.0790 0.0720 0.0470 0.0290 0.0100
Announcement Date 19-03-29 20-03-31 21-03-31 22-03-30 23-03-31 24-04-01
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 8.043 7.396 7.347 8.023 8.241 5.947
EBITDA 1 -1.449 -0.7891 -4.116 -1.025 -1.223 -2.787
EBIT 1 -1.707 -1.067 -4.304 -1.193 -1.417 -2.955
Operating Margin -21.22% -14.42% -58.59% -14.87% -17.19% -49.69%
Earnings before Tax (EBT) 1 -2.078 -0.7777 -5.594 -1.204 -1.365 -4.854
Net income 1 -1.612 -0.6899 -5.483 -1.256 -1.453 -4.806
Net margin -20.04% -9.33% -74.63% -15.66% -17.63% -80.81%
EPS 2 -0.007799 -0.002947 -0.0204 -0.004600 -0.005248 -0.0172
Free Cash Flow 1 -2.296 0.275 -2.311 -0.887 -0.6489 2.505
FCF margin -28.54% 3.72% -31.45% -11.05% -7.87% 42.13%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 19-03-29 20-03-31 21-03-31 22-03-30 23-03-31 24-04-01
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 0.52 0.82 - - 1.1 1.51
Net Cash position 1 - - 1.78 0.32 - -
Leverage (Debt/EBITDA) -0.3601 x -1.04 x - - -0.9012 x -0.541 x
Free Cash Flow 1 -2.3 0.27 -2.31 -0.89 -0.65 2.51
ROE (net income / shareholders' equity) -54.8% -22.2% -138% -35.6% -67.2% 538%
ROA (Net income/ Total Assets) -15% -8.68% -33.7% -9.96% -14.3% -41.9%
Assets 1 10.76 7.944 16.28 12.62 10.17 11.48
Book Value Per Share 2 0.0200 0.0200 0.0200 0.0100 0.0100 -0.0100
Cash Flow per Share 2 0 0 0.0100 0 0 0
Capex 1 0.05 0.07 0.01 0.04 0.08 0
Capex / Sales 0.58% 0.96% 0.18% 0.48% 0.93% 0.08%
Announcement Date 19-03-29 20-03-31 21-03-31 22-03-30 23-03-31 24-04-01
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
HOLISTA COLLTECH LIMITED Stock Holista Colltech Limited
-.--% 1.86M
MODERNA, INC. Stock Moderna, Inc.
+33.63% 50.85B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-0.09% 42.82B
LONZA GROUP AG Stock Lonza Group AG
+49.62% 42.03B
CELLTRION, INC. Stock Celltrion, Inc.
-4.96% 29.55B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+11.18% 26.11B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.95% 19.13B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
+8.61% 13.05B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+28.31% 12.16B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+24.73% 12.08B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. HCT Stock
  4. Financials Holista Colltech Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW